Medtronic (MDT) Other Accumulated Expenses (2014 - 2026)

Medtronic has disclosed Other Accumulated Expenses across 13 years of filings, most recently posting $3.5 billion for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $3.5 billion, down 0.62% year-over-year; the trailing twelve-month figure through Jan 2026 was $3.5 billion (down 0.62% YoY), and the FY2025 annual result was $3.7 billion, up 2.82% from the prior year.
• Other Accumulated Expenses came in at $3.5 billion for Q1 2026 at Medtronic, up from $3.2 billion in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $4.0 billion in Q4 2022 to a low of $3.2 billion in Q4 2025.
• The 5-year median for Other Accumulated Expenses is $3.6 billion (2023), against an average of $3.6 billion.
• Across the five-year window, Other Accumulated Expenses advanced 16.2% in 2022 and decreased 18.16% in 2023, its largest moves.
• Medtronic's Other Accumulated Expenses stood at $4.0 billion in 2022, then declined by 18.16% to $3.3 billion in 2023, then fell by 1.18% to $3.3 billion in 2024, then slipped by 3.28% to $3.2 billion in 2025, then grew by 11.13% to $3.5 billion in 2026.
• The last three Other Accumulated Expenses figures came in at $3.5 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.6 billion (Q3 2025), per Business Quant data.